Cholesterol Crystal Dissolution Rate of Serum Predicts Outcomes in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
Baravan Al-KassouLara Al-KassouThorsten MahnDieter LütjohannJasmin ShamekhiNicola WillemsenSven Thomas NiepmannStephan BaldusMalte KelmGeorg NickenigEicke LatzSebastian ZimmerPublished in: Journal of the American Heart Association (2024)
The CCDR is a novel biomarker associated with outcome in patients with aortic stenosis undergoing transcatheter aortic valve replacement. It may provide new insights into patients' anti-inflammatory capacity and additional prognostic information beyond classic risk assessment.
Keyphrases
- aortic stenosis
- transcatheter aortic valve replacement
- ejection fraction
- aortic valve replacement
- aortic valve
- transcatheter aortic valve implantation
- risk assessment
- end stage renal disease
- anti inflammatory
- chronic kidney disease
- left ventricular
- newly diagnosed
- healthcare
- coronary artery disease
- heavy metals
- type diabetes
- climate change
- patient reported outcomes
- atrial fibrillation
- insulin resistance